Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan.

Sho Suzuki Takuji GotodaChika KusanoHisatomo IkeharaRyoji IchijimaMotoki OhyauchiHirotaka ItoMasashi KawamuraYohei OgataMasahiko OhtakaMoriyasu NakaharaKoichi Kawabe

Published in: Gut (2020)

UMIN000034140.

Keyphrases

helicobacter pylori
low dose
helicobacter pylori infection
study protocol
clinical trial
open label
randomized controlled trial
cross sectional